Urologix Inc Share Price Nasdaq
Equities
US9172731047
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
||
- USD | - |
2016 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
2015 | Urologix Conducting A Strategic Review | CI |
Sales 2013 | 16.48M 1.3B | Sales 2014 | 14.01M 1.11B | Capitalization | 3.66M 290M |
---|---|---|---|---|---|
Net income 2013 | -4M -317M | Net income 2014 | -7M -554M | EV / Sales 2013 | 0.4 x |
Net Debt 2013 | 3.04M 241M | Net Debt 2014 | 4.62M 365M | EV / Sales 2014 | 0.59 x |
P/E ratio 2013 |
-0.8
x | P/E ratio 2014 |
-0.49
x | Employees | - |
Yield 2013 * |
-
| Yield 2014 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 28/05/91 |
Scott Madson
DFI | Director of Finance/CFO | 63 | 31/03/15 |
Lisa Ackermann
SAM | Sales & Marketing | 51 | 15/06/11 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mitchell Dann
FOU | Founder | 63 | 28/05/91 |
Sidney Emery
BRD | Director/Board Member | 74 | 30/09/05 |
Director/Board Member | 57 | 05/08/10 |
1st Jan change | Capi. | |
---|---|---|
+2.06% | 211B | |
+5.69% | 185B | |
+29.31% | 158B | |
+2.36% | 64.32B | |
+18.36% | 55.66B | |
-1.92% | 48.41B | |
-8.37% | 37.82B | |
-1.37% | 35.57B | |
+8.67% | 28.12B |